Stocks to Watch: Zinka Logistics, HCL Technologies, and Biocon in Focus

istics Solutions Quickroutes International is reportedly planning to offload a 9% stake in Zinka Logistics Solutions, aiming to raise Rs 647 crore, according to CNBC-TV18 sources. The floor price for the sale is set at Rs 405 per share. As of March 2025, Quickroutes held a 9.01% stake in the company, making this a significant move for the digital platform for truck operators. ologies HCL Technologies has partnered with UiPath to enhance agentic automation for UiPath’s global customers. This strategic collaboration aims to drive large-scale transformation across industries, enabling more intelligent, self-sufficient business processes with minimal human intervention, marking a step forward in automation innovation. Biocon is gaining attention after receiving approval in India for its Liraglutide drug substance. Its subsidiary, Biocon Pharma, also secured approval for the Liraglutide drug product (6 mg/ml solution for injection in pre-filled pen and cartridge) from the Drugs Controller General of India (CDSCO). This generic version of Victoza is indicated for treating insufficiently controlled Type 2 diabetes, bolstering Biocon’s presence in the diabetes care market.